Eciruciclib

Cat. No. M28970

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Eciruciclib is an antineoplastic and potent cyclin dependent kinase (CDK) inhibitor.

Molecular Weight	488.6
Formula	C27H33FN8
CAS Number	1868086-40-1
Form	Solid
Solubility (25°C)	DMSO 2 mg/mL (ultrasonic and warming and heat to 60°C)
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related CDK Products
(E/Z)-Zotiraciclib citrate (E/Z)-Zotiraciclib citrate is a potent CDK2, JAK2, and FLT3 inhibitor.
Abemaciclib metabolites M2 Abemaciclib metabolite M2 (LSN2839567) is a metabolite of Abemaciclib, acts as a potent CDK4 and CDK6 inhibitor, with IC50 values of 1.2 and 1.3 nM, respectively.
CDK9-IN-1 CDK9-IN-1 is a novel, selective CDK9 inhibitor, with an IC50 of 39 nM for CDK9/CycT1, it can be used for the research of HIV infection.
XO44 XO44 (PF-6808472) is a broad-spectrum covalent kinase probe.
ML 315 ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively.

Catalog